Caroline Laubach, a spinal stroke survivor and full-time wheelchair user, serves as a test pilot for Wandercraft’s AI-powered exoskeleton prototype, which offers more than just new technology—it restores freedom and connection often missing for wheelchair users. Laubach shares that wearing the exoskeleton allows her to walk and engage with people at eye level, making her feel more visible and socially connected. She recognizes the device’s inclusivity for various disabilities and envisions its widespread use enabling users to navigate daily life independently. Wandercraft’s mission centers on enhancing upright mobility and walking independence. Founded in 2012 by Nicolas Simon, Matthieu Masselin, and Jean-Louis Constanza—each motivated by personal ties to mobility challenges—the company aims to help the estimated 80 million wheelchair users worldwide. Their first exoskeleton, Atalante X, is FDA-cleared and European-approved, already deployed in over 100 clinics globally, aiding hundreds of patients in rehabilitation by facilitating over a million steps monthly. Extending beyond clinical use, Wandercraft’s new Personal Exoskeleton prototype—currently in trials in New York and New Jersey—is designed for everyday environments such as home, work, and public spaces. Powered by NVIDIA AI, it adapts smoothly to user movements on varied surfaces and is controlled via joystick, making it accessible to a broad range of abilities. A significant driver of Wandercraft’s innovation is its collaboration with Nvidia, leveraging tools like Nvidia Isaac Sim for virtual testing and healthcare robotics platforms to enhance device responsiveness. This AI integration aims to enable natural walking speeds, street crossing, and stair navigation, making real-world mobility feasible for users. Beyond technology, Wandercraft has established Walk in New York by Wandercraft, a pioneering physical therapy center in Manhattan combining licensed PT services with exoskeleton-assisted walking and neurorehabilitation.

The center offers personalized therapy, advanced gait analysis, virtual reality feedback, and immersive rehab environments, supporting individuals regardless of upper body strength. It will also serve as the hub for deploying and supporting Wandercraft’s Personal Exoskeleton for everyday use. Looking ahead, Wandercraft is pursuing FDA approval for the Personal Exoskeleton and aims to broaden accessibility, including Medicare coverage plans. The company is recruiting clinical trial participants—adults 18+ with motor spinal cord injuries at or above T6—and is developing a volunteer companion network to assist users during sessions. Interested individuals and companions fluent in English or able to communicate via translators can contact Wandercraft at clinicaltrials@wandercraft. health. Despite decades of technological advancement, millions still depend on wheelchairs. Wandercraft’s Personal Exoskeleton, guided by real user experiences like Laubach’s, offers a transformative path forward—restoring independence, social connection, and hope. As reviewer Kurt notes, this innovation is not merely robotics or AI; it empowers people to stand tall and live life on their own terms, making the future of mobility brighter than ever. For more tech insights, security alerts, and exclusive deals, subscribe to the free CyberGuy Report at Cyberguy. com/Newsletter or follow Kurt on Facebook, YouTube, and Instagram. For questions about AI-driven wearable robotics and mobility, visit Cyberguy. com/Contact.